We are monitoring the impact of COVID-19 on Europe Neurotherapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1198
Share on
Share on

Europe Neurotherapeutics Market Research Report – Segmented By Treatment, Disorders, Distribution Channels & Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1198
Pages: 132

The size of the European Neurotherapeutics Market is projected to be rising at a prominent rate between 2021 to 2026.

Europe has the second-highest share in the market due to increasing awareness among people over various neurological conditions.

Neurological conditions result in damage to the brain, spinal nerves or column that is caused by injury or illness. The precise causes for many of the neurological conditions are not yet known. These disorders can affect men and women, young and old and people from all cultures. Some of these neurological conditions are life-long and people can experience them onset at any time in their lives. Some of these conditions like cerebral palsy, are present from birth, and Alzheimer’s disease, Parkinson’s disease affect mainly older people. These disorders involve progressive deterioration in mental and physical capabilities which disrupts the patient and patient’s family. So, Neurotherapeutics are used for the treatment of traumas causing diseases.

Europe Neurotherapeutics Market is mainly driven by increasing aging population, growing R&D expenditure, a better understanding of the nature of neurologic diseases.  Aged population are more susceptible to brain disorders. Therefore, the rise in aging population and life expectancy of the people will increase the market. The restraints that will hamper the growth of the market are restrictions by regulatory bodies on various technologies and drugs.

Based on Treatment, the market is segmented into Neurologic drugs and Neurologic devices. Neurologic drugs are further classified into oral administration, injections and others. Whereas neurologic devices are further categorized into Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS), transcranial magnetic stimulation, Deep Brain Stimulator, and others. Based on disorders, the market is segmented into Central Nervous system (CNS) disorders, Peripheral Nervous system (PNS) disorders, Autonomous Nervous system (ANS) disorders. Based on distribution channels the market is segmented into Hospitals, Neurotherapeutic center, Clinical research organizations, Clinics. Based on Geography, the Europe Neurotherapeutics market is analyzed under various regions namely U.K, Germany, France, Italy and Spain.

Some of the major players in Europe Neurotherapeutics Market are Abbott Laboratories, Inc., Becton, Novartis AG, Dickinson and Company, Pfizer, Inc., Johnson & Johnson, Biogen, Inc., GlaxoSmithKline, Inc., AstraZeneca plc, Sanofi-Aventis, Spiegelberg, stryker, Covidien, Medtronic, GE healthcare, and Merck & Co.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Neurologic Drugs 

                                                5.1.2.1 Oral Administration

                                                5.1.2.2 Injections

                                                5.1.2.3 Others

                                5.1.3 Neurologic Devices             

                                                5.1.3.1 Electroconvulsive Therapy (ECT)

                                                5.1.3.2 Vagus Nerve Stimulation (VNS)

                                                5.1.3.3 Transcranial magnetic stimulation

                                                5.1.3.4 Deep Brain Stimulator

                                                5.1.3.5 Others

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Disorders                    

                                5.2.1 Introduction           

                                5.2.2 Central Nervous system disorder  

                                5.2.3 Peripheral Nervous system disorder            

                                5.2.4 Autonomous Nervous system disorder       

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Distribution Channels                            

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Neurotherapeutic center  

                                5.3.4 Clinical Research organisations      

                                5.3.5 Clinics        

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7 Market Attractiveness Analysis, By Application        

                                5.3.8 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                                6.1.3.3 By Disorders

                                                6.1.3.4 By Distribution Channels

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                                6.1.4.3 By Disorders

                                                6.1.4.4 By Distributional Channels

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                                                6.1.5.3 By Disorders

                                                6.1.5.4 By Distribution channels

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Abbott Laboratories               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Becton                         

                8.3 Novartis AG                

                8.4 Dickinson and Company                       

                8.5 Pfizer                            

                8.6 Johnson & Johnson                 

                8.7 Biogen                          

                8.8 Glaxosmithkline                       

                8.9 AstraZeneca               

                8.10 Sanofi Aventis                        

                8.11 Spiegelberg                             

                8.12 Covidien                    

                8.13 Medtronic                

                8.14 GE Health Care                       

                8.15 Merck & Co                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  2. Europe Neurologic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  3. Europe Neurologic Devices Market, By Region, From 2021 to 2026 (USD Billion)
  4. Europe Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  5. Europe Central Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  6. Europe Peripheral Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  7. Europe Autonomous Nervous system disorders Market, By Region, From 2021 to 2026 (USD Billion)
  8. Europe Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  9. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  10. Europe Neurotherapeutic center Market, By Region, From 2021 to 2026 (USD Billion)
  11. Europe Clinical research organisations Market, By Region, From 2021 to 2026 (USD Billion)
  12. Europe clinics Market, By Region, From 2021 to 2026 (USD Billion)
  13. U.K. Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  14. U.K. Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  15. U.K. Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  16. Germany Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  17. Germany Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  18. Germany Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  19. France Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  20. France Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  21. France Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  22. Italy Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  23. Italy Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  24. Italy Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  25. Spain Neurotherapeutics Market, By Treatment, From 2021 to 2026 (USD Billion)
  26. Spain Neurotherapeutics Market, By Disorders, From 2021 to 2026 (USD Billion)
  27. Spain Neurotherapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Billion)
  28. Europe Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  29. Europe Oral Administrations Market, By Region, From 2021 to 2026 (USD Billion)
  30. Europe Injections Market, By Region, From 2021 to 2026 (USD Billion)
  31. U.K. Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  32. Germany Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  33. France Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  34. Italy Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  35. Spain Neurotherapeutics Market, By Neurologic drugs, From 2021 to 2026 (USD Billion)
  36. Europe Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  37. Europe Electroconvulsive Therapy (ECT) Market, By Region, From 2021 to 2026 (USD Billion)
  38. Europe Vagus Nerve Stimulation (VNS) Market, By Region, From 2021 to 2026 (USD Billion)
  39. Europe Transcranial magnetic stimulation Market, By Region, From 2021 to 2026 (USD Billion)
  40. Europe Deep Brain Stimulator Market, By Region, From 2021 to 2026 (USD Billion)
  41. U.K. Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  42. Germany Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  43. France Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  44. Italy Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)
  45. Spain Neurotherapeutics Market, By Neurologic devices, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample